Ann: Appendix 4E and Annual Report, page-20

yes but the evidence shows otherwise. Yes few options but despite this desperation hardly anybody seems to be using Oncosil.
let’s look at facts again :
• since granting of CE mark almost 18 m ago there will have been between nearly 6000 new lapc cases in uk alone. These are based on company’s numbers, not mine These patients didn’t all vanish because of Covid
• last CR May 2020 company stated 5 UK sites were already onboarded in investor slides. I’d guess these were quite big hospitals.
• former CEO told market during investors call about year ago that those hospitals were actively screening - I wrote the comment down at the time- which means they would have been able to give treatment

But the result ? Zero.